The trajectory of companies tied to the drug's past presents a complex investment landscape. While the initial success generated substantial gains, generic copies have significantly eroded sales . Investing https://sites2000.com/story11470569/copyright-s-flagship-product-and-big-pharma-a-speculative-opportunity